Harvard Medical School and Cellectricon Collaborates Around Whole-Genome RNAi Screening Technology - Cellaxess(R)HT
11/25/2008 11:31:34 AM
GOTHENBURG, Sweden, Nov. 25 /CNW/ - Cellectricon, a leading provider of automated screening solutions for drug discovery, today announced its collaboration with Harvard Medical School, the ICCB-Longwood Screening Facility ("ICCB-L"). Harvard Medical School (ICCB-L) will utilize the Cellaxess(R)HT system, the world's first system for high throughput transfection enabling reagent-free delivery of genetic material to a wide range of biologically relevant cell types.
comments powered by